Novo Nordisk reports an IT security incident with unauthorized access
The incident involved copying of non-public data, including personal data, externally. Core business operations remain unaffected.
See the latest news and media coverage for Novo Nordisk. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare company focused on diabetes and obesity
novonordisk.comLast updated
In short: Novo Nordisk advanced its obesity pipeline with positive CagriSema and Zenagamtide data while expanding the Wegovy pill's global market presence.
The incident involved copying of non-public data, including personal data, externally. Core business operations remain unaffected.
The daily semaglutide tablets offer an alternative to injections for adults with obesity or overweight.
Phase 3 trials showed consistent reductions in blood sugar and weight across type 2 diabetes stages.
Findings from four trials examine outcomes in sleep apnea, asthma, and cardiometabolic risk factors.
Novo Nordisk plans to file for Chinese approval of its Wegovy weight-loss pill, following Eli Lilly's earlier move.
FDA warns telehealth firms about false claims on compounded GLP-1 drugs from Novo Nordisk and Eli Lilly.
The Danish pharmaceutical company Novo Nordisk will 'very soon' apply for approval for the Wegovy tablet in China.
Shadowy company has supplied temporary workers to Novo construction. The company has, according to the Danish Tax Authority, used invoice factories, while a famous and notorious bankruptcy rider also appears in...
Track Novo Nordisk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Novo Nordisk and other trending companies.